- HOME >
- For Researchers >
- Product Search >
- Search Result >
- #10375 Anti-Human SP-A (PE10) Mouse IgG MoAb
Product Search
#10375 Anti-Human SP-A (PE10) Mouse IgG MoAb
- Intended Use:
- Research reagents
- Application:
- IHC
- Package Size1:
- 500 μg
- Package Size2:
- 50 μg
- Note on Application Abbreviations
- IHC:Immunohistochemistry
※ The product indicated as "Research reagents" in the column Intended Use cannot be used
for diagnostic nor any medical purpose.
※ The datasheet listed on this page is sample only. Please refer to the datasheet
enclosed in the product purchased before use.
Product Overview
Product Overview
Product Code | 10375 |
---|---|
Product Name | Anti-Human SP-A (PE10) Mouse IgG MoAb |
Intended Use | Research reagents |
Application | IHC |
Species | Human |
Immunizing antigen | Purified surfactant apoprotein A |
Source | Mouse-Mouse hybridoma |
Clone Name | PE10 |
Subclass | IgG2b |
Purification Method | Affinity purified with Protein A |
Package Form | Lyophilized product from PBS containing 1 % BSA and 0.05 % NaN3 |
Storage Condition | 2 - 8℃ |
Poisonous and Deleterious Substances | Applicable |
Cartagena | Not Applicable |
Package Size 1 | 500 μg |
Package Size 2 | 50 μg |
Remarks1 | The commercial use of products without our permission is prohibited. Please make sure to contact us and obtain permission. |
Product Description
Product Description
Lung surfactant is a lipoprotein complex which is synthesized and secreted into the alveoli of the lung by type II pneumocytes. Its major protein component, surfactant protein-A (SP-A), is a glycoprotein with a reduced denatured molecular mass of 35 kDa, and is a useful immunohistochemical marker for lung adenocarcinoma. The reactivity of PE10 antibody shows that normal type II pneumocytes and pulmonary macrophages are positive for SP-A in the cytoplasm, whereas type I pneumocytes, bronchial surface epithelial cells and bronchial gland cells are devoid of immunoreactivity. Immunoreactivity for SP-A is also seen in reactive hyperplastic type II pneumocytes, and is stronger in the hyperplastic type II pneumocytes than in normal type II pneumocytes. In primary lung adenocarcinoma, the expression of SP-A is almost the same for the various adenocarcinomas classified by the grade of histological differentiation.
References
References
Note: Retrieve by PMID number in displayed by abstract: http://www.ncbi.nlm.nih.gov